Hudson Bay Capital Management
PALI icon

Hudson Bay Capital Management’s Palisade Bio PALI Stock Holding History

Hudson Bay Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Sell
89,386
-567,074
-86% -$1.03M ﹤0.01% 1129
2025
Q4 		$1.54M Buy
+656,460
New +$1.26M 0.01% 746
2019
Q4 		– Sell
-24
Closed -$183K – 484
2019
Q3 		$183K Buy
+24
New +$335K 0.01% 367

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Hudson Bay Capital Management's PALI Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Palisade Bio (PALI) stake by 86% in Q1 2026, selling an estimated $1.03M and leaving 89,386 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Hudson Bay Capital Management first reported a position in PALI in Q3 2019 and has held it in 3 quarters since. The position peaked at $1.54M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Hudson Bay Capital Management held 89,386 shares of Palisade Bio worth $156K as of Q1 2026.
  • Hudson Bay Capital Management sold 567,074 Palisade Bio shares in Q1 2026, an estimated $1.03M.
  • Palisade Bio made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1129 holding.
  • Hudson Bay Capital Management first reported a position in Palisade Bio in Q3 2019 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Palisade Bio position peaked at $1.54M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.